# CD45RA Depleted T-cell Infusion for Prevention of Infections After TCRab/CD19-depleted Allo-HSCT

> **NCT02942173** · PHASE2,PHASE3 · COMPLETED · sponsor: **Federal Research Institute of Pediatric Hematology, Oncology and Immunology** · enrollment: 150 (actual)

## Conditions studied

- Leukemia
- Lymphoma
- Myelodysplastic Syndromes
- GvHD
- Opportunistic Infections
- Graft-versus-Host Disease

## Interventions

- **BIOLOGICAL:** CD45RA-depleted peripheral blood mononuclear cells

## Key facts

- **NCT ID:** NCT02942173
- **Lead sponsor:** Federal Research Institute of Pediatric Hematology, Oncology and Immunology
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-10
- **Primary completion:** 2019-08-21
- **Final completion:** 2020-08-21
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2023-03-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02942173

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02942173, "CD45RA Depleted T-cell Infusion for Prevention of Infections After TCRab/CD19-depleted Allo-HSCT". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT02942173. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*